Statement of Organization, Functions, and Delegations of Authority, 6336-6340 [2021-01213]

Agencies

• Centers for Disease Control and Prevention
• DEPARTMENT OF HEALTH AND HUMAN SERVICES

[Federal Register Volume 86, Number 12 (Thursday, January 21, 2021)]
[Notices]
[Pages 6336-6340]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-01213]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Statement of Organization, Functions, and Delegations of 
Authority

    Part C (Centers for Disease Control and Prevention) of the 
Statement of Organization, Functions, and Delegations of Authority of 
the Department of Health and Human Services (45 FR 67772-76, dated 
October 14, 1980, and corrected at 45 FR 69296, October 20, 1980, as 
amended most recently at 85 FR 70630-70633, dated November 5, 2020) is 
amended to reflect the reorganization of the National Center for HIV/
AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease 
Control and Prevention.
    Section C-B, Organization and Functions, is hereby amended as 
follows:
    Delete in its entirety the title for the National Center for HIV/
AIDS, Viral Hepatitis, STD, and TB Prevention (CVJ) and insert the 
following title National Center for HIV, Viral Hepatitis, STD, and TB 
Prevention (CVJ).
    Revise the mission statement for the National Center for HIV, Viral 
Hepatitis, STD, and TB Prevention (CVJ) and insert the following:
    National Center for HIV, Viral Hepatitis, STD, and TB Prevention 
(CVJ). The National Center for HIV, Viral Hepatitis, STD, and TB 
Prevention (NCHHSTP) maximizes public health and safety nationally and 
internationally through the elimination, prevention, and control of 
disease, disability, and death caused by Human Immunodeficiency Virus 
Infection (HIV), non-HIV retroviruses, viral hepatitis, other sexually 
transmitted diseases (STDs), and tuberculosis (TB). In carrying out its 
mission, NCHHSTP: (1) Builds capacity and enhances public health 
infrastructure for preventing and treating HIV, viral hepatitis, STDs, 
and TB; (2) coordinates activities and programs across CDC and with 
other Department of Health and Human Services Operating Divisions in 
order to maximize the public health impact of HIV, viral hepatitis, 
STDs, and TB interventions; (3) conducts surveillance and research to 
determine the distribution, determinants, and burden of HIV, viral 
hepatitis, STDs, and TB; (4) conducts program evaluation to improve 
programs and activities relating to the prevention of HIV, viral 
hepatitis, STDs, and TB, and determine their impact; (5) provides 
reference laboratory and clinical diagnostic services for HIV, viral 
hepatitis, STDs, and TB to relevant stakeholders; (6) promotes 
collaboration and service integration among HIV, viral hepatitis, STDs, 
and TB programs; (7) engages external partners to develop and implement 
effective HIV, viral hepatitis, STDs, and TB policies, research, and 
programs; (8) engages partners, to promote health equity and reduce 
health disparities among those affected by HIV, viral hepatitis, STDs, 
and TB; (9) provides technical assistance and training in the 
diagnosis, treatment, and prevention of HIV, viral hepatitis, STDs, and 
TB; (10) conducts public health communication activities to disseminate 
research findings and increase awareness of HIV, viral hepatitis, STDs, 
and TB; (11) conducts operational, behavioral, and biomedical research 
to improve the distribution, diagnosis, prevention, and control of HIV, 
viral hepatitis, STDs, and TB; (12) provides scientific leadership 
regarding public health ethics and protection of human subjects linked 
to HIV, viral hepatitis, STDs, and TB; (13) translates research 
findings into public health practice and policy for HIV, viral 
hepatitis, STDs, and TB prevention; (14) plans, coordinates, and guides 
programs and activities with external partners, federal agencies, and 
other organizations related to HIV, viral hepatitis, STDs, and TB 
prevention, care, and treatment; (15) leads and participates in the 
development, implementation, and evaluation of policies and guidelines 
related to HIV, viral hepatitis, STDs, and TB; (16) provides scientific 
leadership regarding screening, treatment, immunization, and other 
prevention interventions relevant to HIV, viral hepatitis, STDs, and 
TB; (17) assures all public health decisions are based on the highest 
quality scientific data, openly and objectively derived; (18) provides 
leadership to assist international partners in establishing and 
maintaining, HIV, viral hepatitis, STDs, and TB screening, treatment, 
immunization, and other prevention and control programs; (19) ensures 
that programmatic and scientific activities are aligned with, and in 
support of, CDC's overall mission, goals, and strategic imperatives; 
(20) allocates and tracks CDC resources and contributes to the 
development of CDC's short-, medium- and long-term strategic plans for 
preventing the spread of HIV, viral hepatitis, STDs, and TB; (21) 
collaborates with other federal agencies, domestic and international 
governmental and non-governmental organizations to advance CDC and 
NCHHSTP health protection goals; and (22) coordinates oversight of the 
NCHHSTP Federal Advisory Committees.
    Delete in its entirety the titles and mission and function 
statement for the Office of the Director (CVJ1) and insert the 
following:
    Office of the Director (CVJ1). (1) Provides leadership and guidance 
on the development of goals and objectives, policies, program planning 
and development, and program management and operations of the 
activities of NCHHSTP and manages, directs, coordinates, and evaluates 
the center's activities; (2) plans and coordinates the annual program 
planning process; (3) coordinates with Office of the Director (OD), 
Centers/Institute/Offices (CIOs), and divisions in determining and 
interpreting operating policy and in ensuring their respective 
management input for specific program activity plans; (4) facilitates 
closer linkages between HIV, non-HIV retroviruses, STDs, viral 
hepatitis, and TB, surveillance activities and prevention programs at 
all levels, and facilitates collaboration, integration, and multi-
disciplinary approaches to enhance the effectiveness of HIV, STD, viral 
hepatitis, and TB prevention programs; (5) facilitates collaboration 
among, and integration of, science and prevention programs throughout 
NCHHSTP and enhances the coordination and integration of HIV, STD, 
viral hepatitis, and TB prevention services for individuals and 
populations at

[[Page 6337]]

increased risk for more than one of these infections; (6) coordinates 
the integration of CDC funding of state and local health departments 
for HIV, STD, viral hepatitis, and TB prevention; (7) maximizes center-
wide collaboration to promote and support Program Collaboration and 
Service Integration (PCSI) in state and local HIV, viral hepatitis, STD 
and TB programs to increase efficiencies and provide comprehensive 
evidence based prevention services to impacted populations; (8) 
develops partnership objectives and strategies for advancing center 
priorities (e.g., on cross-cutting functions PCSI, reducing health 
disparities, etc.) and leverages OD resources to address these 
objectives and strategies; (9) coordinates and tracks health equity 
science and program activities within the center; (10) coordinates and 
tracks science and program activities that concern or address social 
determinants of health within NCHHSTP and other programs; (11) 
collaborates with the CDC OD and other CDC components on health equity 
activities, and works with the CDC OD to monitor progress in meeting 
Executive Orders related to improving minority health; (12) develops 
partnerships with other federal agencies and nongovernmental 
organizations working on similarly-affected populations; (13) supports 
research, surveillance, education, training, and program development to 
achieve health equity and reduce health disparities; (14) sponsors 
workgroups, meetings, and conferences related to health equity; (15) 
promotes a diverse public health workforce through internships, 
fellowships, training programs, and other activities; (16) ensures 
process consistency for laboratory related functions within NCHHSTP and 
across the CIOs; (17) facilitates cross-center decision-making 
regarding laboratory activities; (18) monitors the performance of 
funded extramural research projects in the areas of HIV, viral 
hepatitis, STD and TB; (19) collaborates with other federal agencies to 
advance prevention through healthcare; (20) coordinates and supports 
cross-cutting strategic initiatives in support of NCHHSTP divisions and 
partners; and (21) works across the agency to advance prevention 
priorities.
    Delete item (3) of the functional statement for the Office of the 
Associate Director for Science (CVJ12), and insert the following: (3) 
Facilitates communication regarding scientific and programmatic 
services across the Deputy Director of Infectious Diseases (DDID).
    Delete in its entirety the titles and mission and function 
statements for the Division of HIV/AIDS Prevention--Intervention and 
Support (CVJB).
    Delete in its entirety the titles and mission and function 
statements for the Division of HIV/AIDS Prevention--Surveillance and 
Epidemiology (CVJC) and insert the following:
    Division of HIV Prevention (CVJC). (1) Conducts national HIV 
surveillance, oversees the implementation of HIV prevention and control 
programs, conducts HIV research, and evaluates the impact of division's 
program and research activities in collaboration with other CDC CIOs; 
(2) provides consultation, financial, and technical services to assist 
others in the planning, development, implementation, evaluation and 
overall improvement of HIV prevention programs; (3) conducts research 
into factors affecting the prevention of HIV; (4) provides strategic 
vision, planning, and coordination for implementation of policies and 
programmatic activities that address the Ending the HIV Epidemic 
initiative in collaboration with the center, CDC OD, and other CIO; (5) 
provides strategic direction of program-led science by overseeing the 
refinement of the Division of HIV Prevention's (DHP) scientific 
research agenda and coordination of DHP priorities; (6) counsels 
leadership in building and aligning strategic partnerships at the 
executive-level and communicates internally and externally about 
partnership priorities; (7) works closely with CDC stakeholders on HIV 
surveillance and epidemiologic investigations that require laboratory 
collaboration, and on activities related to the investigation and 
prevention of HIV-related opportunistic infections; (8) promotes 
linkages between health departments' HIV programs, and other 
governmental and nongovernmental partners who are vital to HIV 
prevention efforts; (9) develops preventive health services models, 
recommendations, and guidelines on the prevention of HIV and associated 
illnesses; (10) monitors surveillance of risk behaviors associated with 
HIV transmission, infectious diseases, and other complications of HIV; 
(11) develops methods and guidance, and provides technical assistance 
to support health departments to build capacity for cluster and 
outbreak response; (12) determines risk factors and transmission 
patterns of HIV by conducting HIV surveillance, epidemiologic 
investigations, and research studies; (13) works closely with other 
governmental and nongovernmental agencies, and the health care 
community to enhance and evaluate HIV prevention services in public and 
private health care delivery systems; (14) implements national HIV 
prevention public information programs and assists in developing 
strategic communications activities and services at the national level 
to inform and educate the American public about HIV, especially 
clinical providers, persons with HIV and groups at high risk for 
acquiring HIV; (15) manages, develops and directs the implementation of 
the division data policy, management, and governance, provides IT 
coordination and support for enterprise level shared services, and 
coordinates with other parts of CDC to ensure adherence to CDC's IT 
governance and data modernization policies; (16) provides information 
on HIV to CDC partners, scientific communities, and the general public 
through publications and presentations; and (17) collaborates with 
UNAIDS, the World Health Organization and other partners on HIV 
surveillance and epidemiology.
    Office of the Director (CVJC1). (1) Plans, directs, and evaluates 
activities of the division; (2) serves as the division's liaison to the 
center policy office, the CDC OD, HHS, GAO and OIG, CDC Washington and 
the Office of Appropriations to address inquiries, develop the 
President's budget, review legislation, and support outreach to educate 
policy makers; (3) manages strategic planning and coordinates related 
reporting; (4) identifies, analyzes and addresses policy barriers and 
leads legal assessment efforts; (5) provides strategic direction, 
goals, and priorities to build and evaluate the effectiveness of 
division partnerships, in coordination with DHP branches and offices, 
including expanding public private partnerships, community-level 
partnerships, and engaging special populations; (6) monitors internal 
and external environmental shifts to identify and analyze potential and 
real reputational risk issues and develops responses to anticipated 
issues to lessen their impact; (7) provides critical vision and 
communication counsel to DHP leadership, aligns messaging across the 
division, and develops, coordinates, and finalizes strategic 
communication plans, messaging, partner communications, social media, 
and other communication materials; (8) advances DHP programmatic 
priorities through proactive stakeholder communication and liaises with 
the Center News Media team; (9) develops goals and objectives and 
provides guidance in national HIV prevention policy formulation and 
program planning and development; (10) leads the development and

[[Page 6338]]

provides oversight of the research agenda and ensures the scientific 
integrity of research, surveillance, evaluation, and other scientific 
aspects of HIV prevention, and coordinates these activities with other 
center divisions, CIOs, federal agencies and other prevention partners 
as needed; (11) oversees and coordinates prevention and control program 
implementation and coordinates activities with other center divisions, 
CIOs, federal agencies, and other prevention partners; (12) provides 
oversight for the integrity and quality of division science, including 
review of protocols and other scientific products and projects, 
scientific clearance, and compliance with all federal rules and 
regulations regarding research and non-research projects, and conducts 
scientific training; (13) coordinates international HIV activities of 
the division and ensures inter-divisional coordination within the 
center and CDC, as appropriate; (14) in the international setting, 
evaluates biomedical, structural, or combination interventions to 
prevent HIV infection and reduce HIV morbidity and mortality; (15) in 
the international setting, conducts and facilitates diagnostic 
evaluations and epidemiologic investigations to increase the diagnosis 
and prevention of HIV infection; (16) provides support and guidance for 
program management and operations, including the coordination and 
development of CDC and division-wide training and educational programs, 
workforce development and succession planning; (17) provides 
management, oversight, and services support for intramural and 
extramural program management; (18) provides health equity strategic 
vision for the division, offices, and branches and collaborates with 
branches to monitor progress toward achieving national agency, center 
and division health equity goals; (19) leads the development and 
provides oversight of the health equity research and programmatic 
agenda for the division, and serves as liaison to key stakeholder 
groups related to health inequities and HIV issues; (20) oversees and 
coordinates the development, maintenance, and reporting of national 
indicators for the prevention of HIV by working with HHS, other federal 
agencies, and partners; (21) provides support and reviews logic models 
and performance measures for Notice of Funding Opportunity 
Announcements for the division; (22) conducts data driven reviews for 
program planning and performance assessment; (23) oversees, develops, 
and directs the division's data policy framework, data management 
framework, and data governance implementation; (24) coordinates with 
other parts of CDC to ensure adherence to CDC's IT governance and data 
modernization policies; (25) manages the acquisition, receipt, quality 
assessment, and provisioning of non-CDC data resources; and (26) 
provides division-level IT/Informatics coordination and support for 
enterprise-level shared services.
    HIV Research Branch (CVJCB). (1) Designs and conducts clinical, 
epidemiologic, implementation, health services, and behavioral research 
studies and trials to increase HIV diagnosis, prevention, and 
treatment, and to optimize health outcomes of people with HIV; (2) 
conducts implementation research to understand and evaluate strategies 
to increase uptake, delivery and sustainability of HIV prevention 
interventions; (3) designs and conducts research to understand 
determinants of disparities, including social determinants of health, 
and to promote health equity in HIV prevention and treatment; (4) 
conducts studies to evaluate, improve, and standardize laboratory 
technologies used for diagnosis and monitoring of HIV infection and for 
supporting adherence to biomedical HIV prevention and treatment 
interventions; (5) conducts demonstration projects of novel prevention 
strategies delivered by health departments, community-based 
organizations (CBO), healthcare organizations, and other providers; (6) 
contributes to the field of HIV prevention by producing and 
disseminating scientific evidence and by providing expert consultation 
to stakeholders; (7) collaborates with key stakeholders in identifying 
research priorities and in designing and conducting research; (8) 
supports partners in investigating unusual HIV transmission and cluster 
and outbreak investigations; and (9) participates in the development of 
guidelines, based on scientific investigations and clinical trials, for 
HIV prevention and for prevention of adverse outcomes of HIV infection.
    Behavioral and Clinical Surveillance Branch (CVJCC). (1) Conducts 
surveillance of behaviors related to acquisition or transmission of HIV 
infection in high risk populations to evaluate the impact of the 
national or jurisdiction's overall prevention portfolio to direct 
prevention resource allocation; (2) develops, uses, and disseminates 
methods to monitor behaviors associated with HIV transmission or 
acquisition; (3) conducts clinical surveillance through in-depth 
interviews of persons with diagnosed HIV to assess access to medical 
care and prevention services, adherence to therapy, and behavioral risk 
associated with HIV transmission; (4) conducts clinical surveillance 
through in-depth chart reviews of persons with diagnosed HIV in 
selected sites to monitor morbidity and mortality and to assess access 
to and quality of care; (5) develops, uses, and disseminates methods to 
monitor clinical care and health outcomes for people with diagnosed 
HIV; (6) conducts behavioral or clinical surveillance in special 
populations of epidemiologic importance; (7) maintains, analyzes, and 
disseminates information from national surveys of behaviors associated 
with HIV testing, prevention, acquisition, or transmission; (8) 
collaborates with internal and external partners to ensure high quality 
behavioral and clinical monitoring systems, including screening for, 
and monitoring of comorbidities in key populations; (9) oversees and 
manages intramural and extramural funding, ensures regulatory 
compliance, provides technical assistance, and monitors program 
implementation related to behavioral and clinical surveillance; (10) 
provides support for outbreak response; and (11) provides subject 
matter expertise and support related to high risk populations and to 
medical care for people with HIV.
    Quantitative Sciences Branch (CVJCD). (1) Designs, develops, and 
implements statistical, data science, economic, cost, and resource 
allocation strategies, models, and methodologies; (2) collaborates with 
scientists, program experts, and senior public health officials 
throughout the division to apply quantitative science models and 
methodologies to HIV surveillance and prevention studies and prevention 
program activities; (3) develops and implements mathematical models to 
project the effects of prevention and care interventions on future HIV 
incidence, prevalence, transmission rates, and costs associated with 
HIV to determine the most efficient allocation of HIV prevention 
resources; (4) develops and reviews the statistical content of study 
designs and protocols, analysis plans, and scientific and communication 
products; and (5) applies novel analytic algorithms and visualization 
approaches to extract actionable HIV-prevention-related information 
from suitable non-traditional data types and sources.
    HIV Surveillance (CVJCE). (1) Conducts population based, national 
HIV surveillance to monitor and characterize HIV trends, transmission 
risk, clinical outcomes, and

[[Page 6339]]

antiretroviral resistance to guide public health action at the federal, 
state, and local levels; (2) develops and implements HIV surveillance 
technical guidance, methods, protocols, and program standards for 
analysis and data system applications for the collection, evaluation, 
analysis, security and confidentiality, and dissemination of HIV 
surveillance data; (3) maintains, analyzes, integrates and disseminates 
information from the national HIV surveillance and related systems; (4) 
promotes uses of surveillance data to inform HIV prevention and care 
efforts, resource allocation, public health policy development and 
evaluation; (5) conducts projects for populations of epidemiologic 
importance and advancement of surveillance methods; (6) evaluates HIV 
surveillance systems, develops and implements improved surveillance 
methodologies, and conducts data driven technical assistance; (7) 
oversees and manages extramural funding for surveillance activities and 
provides programmatic, budgetary, and technical assistance to state and 
local health departments and other external partners to ensure high-
quality state, local and national HIV surveillance data; (8) 
collaborates with internal and external partners and supports cluster 
and outbreak detection and investigation; and (9) collaborates with 
internal and external stakeholders to enhance surveillance quality, 
data use, and provide expert consultation.
    Laboratory Branch (CVJCG). (1) Conducts studies of HIV and other 
human and zoonotic retroviruses, including the diseases they cause and 
their modes of transmission, through virus detection, isolation, and 
characterization by virologic, molecular, and cellular biologic 
methods; (2) collaborates with DHP and other investigators to conduct 
HIV epidemiologic and surveillance studies as they pertain to testing, 
prevention, and intervention strategies; (3) conducts and supports 
field and clinical studies for HIV prevention; (4) develops 
collaborations with other CDC and non-CDC scientists to promote 
scientific progress and accomplishments; (5) collaborates with industry 
to promote commercialization of useful technology, methodologies, or 
reagents of public health importance; (6) serves as a reference 
laboratory for state and local health departments; (7) conducts studies 
related to the development, evaluation, improvement, and 
standardization of laboratory technologies used for the diagnosis, 
surveillance, and monitoring of HIV infection both independently and in 
collaboration with the biotechnology industry; (8) performs HIV testing 
in support of the diagnostic, surveillance, and epidemiologic 
requirements of CDC-based and CDC-affiliated studies of HIV; (9) 
provides diagnostic services to other federal agencies, academic 
centers, CDC-affiliated studies with other countries, and community 
organizations, as appropriate; (10) develops and evaluates novel 
biomedical prevention and treatment modalities in preclinical animal 
models; (11) evaluates and develops HIV testing technologies; (12) 
researches, develops, and evaluates bioinformatics tools to better 
understand HIV spread to inform prevention efforts; (13) provides 
antiretroviral drug testing in support of clinical, preclinical, and 
surveillance activities; and (14) collaborates with internal and 
external partners and supports cluster and outbreak detection and 
investigation.
    HIV Prevention Capacity and Development Branch (CVJCH). (1) 
Assesses HIV prevention and treatment training and technical assistance 
needs of DHP program funding recipients, clinicians, and other HIV 
prevention service providers and develops and delivers strategies and 
products to address identified needs; (2) develops, maintains, and 
manages systems to ensure that health department and CBO staff receive 
appropriate and timely training and technical assistance; (3) provides 
subject matter expertise on HIV prevention and treatment to ensure that 
training and technical assistance products developed by capacity 
building providers are aligned with HHS and CDC strategic goals and 
objectives, center and DHP priorities, and support the training and 
technical assistance needs of DHP program funding recipients, 
clinicians, and other HIV prevention service providers; (4) 
collaborates with DHP staff and capacity building providers to 
synthesize research findings and disseminate technical assistance and 
training products relevant to the needs of HIV prevention programs and 
clinicians; and (5) manages national conference contract and support 
services.
    Prevention Communications Branch (CVJCI). (1) Develops, 
disseminates, and evaluates evidence-based HIV messages, communication 
campaigns, programs, and partnership efforts through multiple channels 
to stakeholders, health care providers, persons at risk for and living 
with HIV, and the general public; (2) maintains division communication 
infrastructure, including social media, Web, and SharePoint channels, 
the curation of CDC's HIV print inventory, and oversight of the HIV 
subject matter expertise of CDC-INFO; and (3) collaborates and consults 
with CDC staff, HHS, state and local health departments, and other 
groups and organizations involved in HIV prevention communication 
activities to devise and facilitate technical assistance systems and 
activities related to the application of social marketing and 
communication science to prevention programs and policies.
    Program Development and Implementation Branch (CVJCJ). (1) In 
collaboration with state and local public health and non-governmental 
national, regional, and local partners, CIOs, and other federal 
agencies, develops and implements programs, policies, and activities 
that enable and mobilize affiliates and communities to become involved 
with, and support, strategic community planning that improves HIV 
prevention programs and activities; (2) plans, develops, implements, 
and manages strategies and resources that build a comprehensive public 
health-private sector partnership to prevent HIV and its complications; 
(3) provides technical consultation and assistance to local, state, and 
territorial health departments, integrated HIV prevention and care 
planning groups, non-governmental, other prevention partners, and 
tribal governments and organizations in operational aspects of HIV 
prevention; (4) monitors implementation and maintenance of HIV 
prevention programs through the application of program science to 
ensure operational objectives are being met; (5) establishes guidance 
and policies for implementation and continuation of local, state, and 
territorial HIV prevention programs; (6) provides technical review of 
grant applications and prevention work plans; (7) coordinates program 
development and implementation with local, state, and territorial 
integrated HIV prevention and care planning groups; (8) facilitates 
linkages with HIV and other infectious diseases prevention programs at 
all levels to maximize coordination of harm reduction and intervention 
strategies tailored for populations with complex psychosocial 
prevention needs; (9) works with national partners to foster HIV 
prevention capabilities and activities in affected communities; (10) 
monitors the progress of funded recipients implementing HIV prevention 
programs and activities; (11) promotes and facilitates the application 
of social marketing principles to HIV prevention at the state and local 
levels; (12) plans, implements, and manages DHP's programmatic notice 
of funding opportunities (NOFOs) for health

[[Page 6340]]

departments, community-based organizations, and national partners and 
providers; (13) provides monitoring and oversight to programmatic NOFO 
activities throughout the funded lifecycle; (14) supports the federal 
Ending the HIV Epidemic workforce that provides technical consultation 
and direct assistance to state, local health departments implementing 
HIV prevention programs; and (15) assesses training, capacity building 
and technical assistance needs and develops strategies to address the 
training of recipient organizations and other external partners 
involved in HIV prevention programs and activities.
    Translation and Evaluation Branch (CVJCK). (1) Collaborates with 
DHP, CDC, HIV prevention program recipients, and national partners to 
systematically collect, process, and use HIV prevention program data 
and research findings for program planning, monitoring, evaluation, and 
improvement; (2) identifies and prioritizes program needs and research 
gaps, synthesizes research and program findings, selects and translates 
HIV prevention research findings, and collaborates within DHP to 
support development and dissemination of guidelines, research syntheses 
and effective strategies for HIV prevention programs; (3) creates, 
maintains and regularly updates a public-facing platform to disseminate 
evidence-based prevention strategies and research syntheses aligned 
with DHP and national prevention priorities to internal and external 
stakeholders; (4) creates and manages a continuously updated multi-
level coded cumulative database of the HIV prevention research 
literature in support of systematic reviews and guideline development 
as well as internal and public inquiries; (5) seeks to advance the 
methodology of HIV prevention evaluation through CDC evaluation 
activities and with the field of program evaluation more broadly; (6) 
seeks to improve data quality and support through providing assistance 
to recipients to help design and implement data collection, design 
local evaluations, and dissemination packages; (7) collects information 
to verify that what is developed, translated and disseminated is 
feasible, programmatically effective, and plays a role in improving 
health outcomes; (8) plans, develops, implements, and manages research 
dissemination strategies and resources that build a research to 
practice infrastructure to prevent HIV and its complications; (9) 
monitors implementation and establishes protocols for implementation of 
behavioral, biomedical, structural evidence-based and evidence-informed 
approaches by HIV prevention programs to determine if said approaches 
may be successfully implemented under real world conditions; (10) 
collaborates and consults with CDC staff, other Public Health Service 
agencies, state and local health departments, CBOs, and other groups 
and organizations involved in HIV prevention activities to support 
technical assistance systems and other activities related to the 
application of evidence-informed and evidence-based prevention programs 
and policies; (11) provides scientific expertise, quality assurance and 
clearance for products and processes related to systematic review, 
research synthesis, and guidelines methodologies; and (12) collaborates 
within DHP to provide technical consultation and assesses and 
determines the training, capacity building, and technical assistance 
needs for organizations implementing behavioral, biomedical, and 
structural evidence-based and evidence- informed approaches to meet the 
unique HIV prevention needs of local jurisdictions based upon risk 
factors and demographics.
    Detection and Response Branch (CVJCL). (1) Develops and 
disseminates analytic methods for detecting and prioritizing clusters 
and outbreaks and understanding transmission patterns, molecular 
epidemiology, and drug resistance; (2) analyzes data to identify and 
monitor priority clusters and support public health action; (3) 
provides technical assistance and other support for health departments 
on detecting clusters and outbreaks; (4) develops, evaluates, and 
disseminates methods for responding to clusters and outbreaks; (5) 
develops guidance and provides technical assistance to support health 
departments to build capacity for cluster response and response 
planning, including community engagement; (6) leads cross-division 
collaboration and communication about cluster and outbreak detection 
and response and builds DHP capacity to support response, including 
training and rostering staff; (7) provides technical assistance and 
other support for health departments on responding to clusters and 
outbreaks and disseminates findings of these responses; (8) analyzes 
information from cluster detection and response to inform efforts to 
prevent clusters and outbreaks; (9) provides scientific and 
programmatic oversight and guidance for DHP informatics systems for 
cluster detection and response and collaborates with other DHP branches 
and offices on these systems; and (10) collaborates with other branches 
and offices in DHP, divisions in the center, and CIOs to harmonize 
scientific agendas and programmatic priorities and addresses community 
engagement and policy issues related to cluster detection and response.
    Delete item (2) of the functional statement for the Division of 
Adolescent and School Health (CVJJ), and insert the following: (2) 
Identifies and monitors priority sexual health risks and related health 
behaviors among youth that result in the transmission of HIV, other 
sexually transmitted infections and unintended pregnancy.
    Delete item (2) of the functional statement for the Program 
Development and Services Branch (CVJJB), and insert the following: (2) 
Uses the results of surveillance and evaluation research and research 
syntheses to improve the impact of school- and community-based 
interventions designed to reduce priority health risks among youth and 
to promote changes in behaviors related to HIV, other sexually 
transmitted diseases, and unintended pregnancy.

Sherri Berger,
Chief Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2021-01213 Filed 1-19-21; 8:45 am]
BILLING CODE 4160-18-P